SEH inhibitor-7
SEH inhibitor-7 (compound c-2) is an inhibitor of soluble epoxide hydrolase (sEH) with IC50s of 0.15 μM (mouse sEH) and 6.2 μM (human sEH), respectively. soluble epoxide hydrolase (sEH) plays an important role in the metabolism of endogenous chemical mediators involved in the regulation of blood pressure and inflammation[1].
Product Specifications
CAS Number
340221-20-7
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Epoxide Hydrolase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/seh-inhibitor-7.html
Purity
99.50
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(NC1=CC=C(OC)C=C1)CC2CCCCC2
Molecular Formula
C15H21NO2
Molecular Weight
247.33
Precautions
H302, H315, H319
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
SHBG (Sex Hormone Binding Globulin) (SHBG/245), CF405S conjugate, 0.1mg/mL
MHC II (HLA-DP) (beta chain) (Bra-14), CF488A conjugate, 0.1mg/mL
Spastin (Sp 3G11-1), CF640R conjugate, 0.1mg/mL
Cytokeratin 17 (E3), CF640R conjugate, 0.1mg/mL
